What is the respiratory MRSA?
Staphylococcus aureus (STAPH) is a very common bacterium that can cause mild skin, mouth and respiratory infections. Most Staf tribes are easy to treat with common antibiotics such as meticillin and penicillin. However, some tribes have developed resistance to antibiotics over the past few decades and are therefore very difficult to treat. Staphylococcus aureus resistant to methicillin (MRSA) is a highly contagious voltage that can cause epidemics in hospitals, schools, children's care centers and other places where large groups share common space. Respiratory MRSA occurs when bacteria inserts into the lungs and neck, which can lead to life -threatening respiratory problems and general diseases.
respiratory infections can be primary or secondary. Primary infections begin in the airways and can be obtained when bacteria are inhaled from the sneezing or coughing of another person. Bacteriedo lungs can also introduce non -sterilized respiratory tubes used in hospitals. Secondary infectionThey usually enter the body through the wound of the skin and eventually travel to the lungs through blood circulation. Symptoms of respiratory MRSA can develop rapidly, sometimes within a few days or hours after the initial infection.
The most common symptoms of respiratory MRSA are fever, fatigue, chest pain and breathing problems. A person can experience shortness of breath, cough, nausea and headaches. Muscles and joints tend to feel painful and can be very unpleasant or impossible even sitting upright in bed. A potentially fatal case of pneumonia can set if the condition is not recognized and immediately treated. If MRSA migrates from the lungs to other main organ systems, including kidneys and hearts.
Fast diagnosis and treatment are necessary to prevent serious lung damage. Patients are typical of the quarantine in sterile hospital rooms to reduce the risk of spreading infection to other patients and healthcare workers. PatternBlood and sputum are collected and cultivated in the laboratory to identify a specific Staf tribe. In most cases, a team of specialists together determines to determine the best treatment.
The first aim of the treatment of respiratory MRSA is to stabilize breathing and heart rate. The patient may be given oxygen through the mask or respiratory tube. Intravenous fluids and blood pressure medicines are given to make the kidneys, liver and heart properly function. In most cases, there are several different types of antibiotics, including clindamycin and tetracycline, administered intravenously in an effort to stop the spread of infection and kill existing bacteria. Depending on the effectiveness of antibiotics and the severity of symptoms, the patient may have to remain in the hospital for several weeks.
As soon as antibiotics prove to be Effective and the patient is stable, he is usually provided by an oral regulation that would take two to four weeks at home. Family members, collaborators or others who were in close contact with the patient are encouragingNi to screen for MRSA. Most outbreaks may be contained when patients follow the instructions of their doctors to use drugs and limiting close personal contact.